Search Results for:
-
ELAN TESTS STEROID AGAINST AIDS
In preliminary clinical trials in San Francisco, the steroid dehydroepiandrosterone (DHEA) is being given to 23 HIV- infected menBioWorld Today | Friday, November 15, 1991 -
FDA ACCELERATES DRUG APPROVAL PROCESS
The plans include use of non-FDA contractors to review drugs, adoption of rules that accelerate the approval process -- including greater use of surrogate markers in clinical trials -- harmonizing drug approvals with foreign countries, and management improvements at the FDA...The development of common procedures would reduce the requirement to duplicate clinical trials in different countries and would "speed the approval of drugs worldwide," said HHS Director Louis SullivanBioWorld Today | Thursday, November 14, 1991 -
HOW THE PROCESS WILL CHANGE
Sponsors will be allowed to negotiate with the FDA to obtain certain data from post-marketing studies now required in Phase III clinical trials...U.S. Recognition of Foreign Approvals The United States will develop with modern industrialized countries common standards for clinical trials, submission of drug approval applications, requirements for animal testing, good manufacturing practices, plant inspections and so onBioWorld Today | Thursday, November 14, 1991 -
TIME SAVED WITH ACCELERATED APPROVAL
8 (Phase III) Major Reasons for Savings: Fewer clinical trials (acceleratedBioWorld Today | Thursday, November 14, 1991 -
SURROGATE MARKER NIXED BY FDA PANEL
Members called for shorter clinical trials to speed the development of a vaccineBioWorld Today | Wednesday, November 13, 1991 -
PHYTON TO DEVELOP TAXOL WITH SQUIBB
Taxol has shown promise in Phase III clinical trials for recurrent ovarian cancer and is also in Phase II trials for breast cancerBioWorld Today | Wednesday, November 13, 1991 -
SOCIETY OF NEUROSCIENCE CONFERENCE
Cellular has treated more than 200 rodents over the past year and a half, said Dr. Seth Rudnick, the company's president and chief executive and plans to begin clinical trials by the end of 1992BioWorld Today | Wednesday, November 13, 1991 -
CNTF ENHANCES SURVIVAL OF MOTOR CELLS
Tarrytown, N.Y.-based Regeneron plans to file an investigational new drug application by mid-1992 to begin clinical trials of CNTFBioWorld Today | Wednesday, November 13, 1991 -
BROCADES TO MARKET LIDAKOL IN EUROPE
Brocades, a Yamanouchi Group company, will cover the costs of clinical trials, regulatory approvals, manufacturing development and scale-up, and marketing and distribution, subject to milestone performance by LidakBioWorld Today | Tuesday, November 12, 1991 -
CENTOCOR LOSES $34.9 MILLION IN QUARTER
30, which the company attributed to aggressive investment in marketing in Europe and the United States, and increased research and development costs associated with its four products in clinical trials...Centocor last week said it plans to begin Phase III clinical trials of Centara, its anti-CD4 compound to treat rheumatoid arthritis, sometime in 1992. (c) 1997 American Health ConsultantsBioWorld Today | Monday, November 11, 1991 -
GREENWICH RAISES $15M IN PRIVATE PLACEMENT
The funds, along with $5.5 million in cash already held by the Fort Washington, Pa., company, will be used to complete clinical trials and support commercialization of Therafectin and to continue clinical development of GW-80126BioWorld Today | Friday, November 8, 1991 -
CELTRIX WILL MERGE WITH BIOGROWTH
and a Chiron Corp./Ciba-Geigy collaboration have IGF without binding protein in clinical trials, said PharrissBioWorld Today | Thursday, November 7, 1991 -
FDA APPROVES EXPANDED DERMAGRAFT TRIALS
said Wednesday that it has received Food and Drug Administration approval to expand clinical trials of Dermagraft, its living dermal replacement product, from 12 to 24 burn centersBioWorld Today | Thursday, November 7, 1991 -
IMMUNEX TO TEST IL-1 AGAINST ALLERGENS
said Tuesday that it is beginning Phase I clinical trials of soluble interleukin-1 receptor to inhibit allergic reactions to skin allergens...Later this year, Immunex plans clinical trials of IL-1 receptor to treat rheumatoid arthritisBioWorld Today | Wednesday, November 6, 1991 -
GENTA FILES 'QUIET' IPO
The San Diego-based company in August filed to begin Phase I/II clinical trials of its antisense compound to treat chronic myelogenous leukemiaBioWorld Today | Tuesday, November 5, 1991 -
PET CANCER TREATMENT CONDITIONALLY APPROVED
The company also said it plans to expand clinical trials of the drug in humansBioWorld Today | Tuesday, November 5, 1991 -
GENZYME GETS DIAGNOSTIC ENZYME BUSINESS
The subsidiary will market Genzyme products directly in Europe, as well as move products through European clinical trials and regulatory approvalBioWorld Today | Tuesday, November 5, 1991 -
FDA APPROVES TRIALS OF PSORIASIS DRUG
has received Food and Drug Administration approval to begin a Phase I clinical trial of its rationally designed drug for topical treatment of psoriasis, the company announced on MondayBioWorld Today | Tuesday, November 5, 1991 -
ALTEON RAISES $45 MILLION IN IPO
The company expects the drug to enter Phase II/III clinical trials in the first half of 1992BioWorld Today | Monday, November 4, 1991 -
GROWTH HORMONE TRIALS ON PATIENTS WITH HIV
said Friday that it has begun Phase I clinical trials of BioTropin recombinant human growth hormone in patients with HIVBioWorld Today | Monday, November 4, 1991
Category
Current Filters
- xclinical trials
Related Keywords
Categories
- x BioWorld Today (9780)
- x BioWorld International (1967)
- x BioWorld Insight (1209)
- x Bio Perspectives (297)
- x State of the Industry Report (131)
- x BioWorld Genomics Review (58)
- x Top 25 Drug Report (43)
- x BioWorld Snapshots (29)
- x Biotech Innovations (17)
- x Market-Leading Biotech Drugs (12)
- x RNAi Report (11)
- x BioWorld Phase III Report (7)
- x Executive Compensation Report (4)
- x Recorded (4)
- x Upcoming (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.